SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-200954
Filing Date
2020-07-28
Accepted
2020-07-28 16:01:53
Documents
3
Period of Report
2020-07-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d857063d8k.htm 8-K 22287
2 EX-3.1 d857063dex31.htm EX-3.1 49964
3 EX-3.2 d857063dex32.htm EX-3.2 131489
  Complete submission text file 0001193125-20-200954.txt   204987
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39397 | Film No.: 201053887
SIC: 2834 Pharmaceutical Preparations